📰 Human Use News
Page 145 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
April 25, 2022
Basel, 25 April 2022 Group sales increase 11%1 at constant exchange rates (CER) and 10% in Swiss francsPharmaceuticals Division sales up 6%; continued strong sales of new medicines
April 25, 2022
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - April 25, 2022 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and
April 25, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
April 25, 2022
By Natalie Grover LONDON/PARIS (Reuters) -French drugmaker Valneva said on Monday that the European Medicines Agency (EMA) had asked for more data on ...
April 25, 2022
PARIS: Valneva s shares tumbled on Monday after the French company said The European Medicines Agency (EMA) has asked for more data on its COVID 19 va...
April 25, 2022
Capmatinib for lung cancer and mosunetuzumab for follicular lymphoma have been recommended for approval in the European Union.
April 25, 2022
By Natalie Grover LONDON/PARIS (Reuters) -French drugmaker Valneva said on Monday that the European Medicines Agency (EMA) had asked for more data on ...
April 25, 2022
By Natalie Grover LONDON/PARIS (Reuters) -French drugmaker Valneva said on Monday that the European Medicines Agency (EMA) had asked for more data on ...
April 22, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
April 22, 2022
In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resectable Stage II-III NSCLC compared with best supportive careMore